Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the efficacy of subcutaneous administration of MIRCERA every two weeks, versus no ESA therapy, in CKD patients with anaemia after kidney transplant not currently treated with ESA.
Critère d'inclusion
- Anemia renal crónica,This study is being performed to investigate the efficacy, safety and tolerability of administration of MIRCERA to anaemic patients with chronic kidney disease and reduced renal function following renal transplant, who are not expected to be considered for dialysis during the course of the study. Hereafter for the purposes of this protocol this population will be referred to as ‘post renal transplant anaemia’ patients